- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03646656
Heart Health Buddies: Peer Support to Decrease CVD Risk (HHB)
Heart Health Buddies: Peer Support to Decrease Cardiovascular Risk (CDA 13-263)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A total of 24 Veterans enrolled at the Durham Veterans Affairs Medical Center will be screened and enrolled. Eligible Veterans are 35-64 years old, with at least one uncontrolled or poorly controlled risk factor for CVD. In addition, 3-6 veterans will be enrolled and trained as heart health peer coaches, with eligibility being 35-64 years old, with at least one documented CVD factor who have sustained improvement in physical activity or dietary change in the previous 3-6 months. All participants complete a baseline assessment, three structured group meetings, and a 12 week post-intervention assessment. At the first group, each participant creates a behavioral goal, and peer partners are paired with another Veteran based on behavioral goal and gender. They are expected to call their peer once a week to discuss progress or difficulty with their action plan and support each other with problem solving. Post enrollment and prior to the first group meeting, Peer coaches will have 3-5 hours of motivational and communication training with study staff focusing on skills such as active listening, non-directive support, eliciting change-talk, promoting incremental change, and patient confidentiality. Peer coaches will interact with peer buddies during a) group sessions, b) at a 6 week phone check-in, and c) on-going support if needed. Additional support will be initiated if there are no phone calls between pairs, there is a lack of participant engagement in calls to partner or attending group sessions, or upon request by the peer. There are two Aims of the current pilot study. Aim 1: examine the feasibility and acceptability of a 12-week hybrid peer coach-reciprocal peer support intervention. Feasibility will be evaluated by ease of recruitment, and enrollment and retention rates. Acceptability will be assessed by self-report of amount, frequency and modality of contacts, participation rates for group sessions, and through post-intervention qualitative interviews.
Aim 2: explore gender differences in feasibility/acceptability of the hybrid peer support model. Gender differences will be evaluated through qualitative comparison of participant reported experiences with intervention content as well as peer and group interactions by gender; and, quantitatively via exploration of differences in enrollment, retention, refusal reasons and frequency of peer contacts.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705-3875
- Durham VA Medical Center, Durham, NC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Peer partners and peer coaches:
- Enrolled in a Durham Veterans Administration Health Care System primary care clinic (including the women's health clinic)
At risk for cardiovascular disease as defined by having at least one of the following:
- Uncontrolled hypertension
- history of obesity defined as (BMI >30)
- uncontrolled non-insulin dependent diabetes mellitus
- In addition, Peer coaches have made and sustained a behavioral change in past 3-6 months to improve heart health
- English as preferred language
- no significant hearing impairment
- lives approximately 30 minutes from the Durham Veterans affairs Medical Center
- agrees to attend regular visits per study protocol
- no contraindication to engage in at least moderate physical activity
- willing to use personal phone for peer and coach contacts
Exclusion Criteria:
- insulin-dependent diabetes
- serious mental illness defined as schizophrenia, bipolar disorder, dementia, active psychosis psychiatric hospitalization within the last 12 months or current high-risk suicide flag in their electronic medical record
- active substance use as documented in electronic or positive screening during telephone screening
- limited Life expectancy (<6 months) or severely ill defined as enrolled in hospice or actively undergoing chemotherapy or radiation therapy for cancer
- currently pregnant or planning to become pregnant in next 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: peer partner
Veterans with at least one CVD risk factor who are interesting in increasing heart healthy behaviors through peer support
|
Peers and peer coaches provide mutual or one-way support to initiate and sustain behavioral improvements for cardiovascular health, with additional education from study staff.
|
|
Other: peer coach
Veterans with at least one CVD risk factor who have made and sustained changes in diet or exercise in the past 3-6 months prior to enrollment.
While the investigators will collect data on peer coach participants, their participation is primarily as part of intervention to examine the feasibility and benefit of adding peer coaching to a peer partner intervention.
|
Peers and peer coaches provide mutual or one-way support to initiate and sustain behavioral improvements for cardiovascular health, with additional education from study staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Enrollment
Time Frame: 12 weeks
|
Number of participants contacted, screened and enrolled in the pilot
|
12 weeks
|
|
Feasibility Retention
Time Frame: 12 weeks
|
Retention rates from consent to enrollment and from enrollment to completion of study.
|
12 weeks
|
|
Acceptability
Time Frame: 12 weeks
|
Acceptability of study based on successful peer buddy contacts per pair (not applicable to coaches) and participation in group sessions.
|
12 weeks
|
|
Acceptability - Weeks Contact With Peer Buddy
Time Frame: 12 weeks
|
Acceptability of study based on successful peer buddy contacts per pair (not applicable to coaches)
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gender Differences - Retention
Time Frame: 12 weeks
|
Quantitative and qualitative gender differences in feasibility and acceptance will be evaluated through quantitative differences in enrollment, retention and frequency of peer contacts, and qualitative comparison of participant-reported experiences with intervention content, peer and group interactions by gender.
Data are presented only for reciprocal peer partner group as this was pre-specified to compare outcomes between men and women in the reciprocal peer partner group.
Thus, peer coaches are not described in this outcome.
|
12 weeks
|
|
Gender Differences-enrollment
Time Frame: 12 weeks
|
Quantitative and qualitative gender differences in feasibility and acceptance will be evaluated through quantitative differences in enrollment, retention and frequency of peer contacts, and qualitative comparison of participant-reported experiences with intervention content, peer and group interactions by gender.
Data are presented only for reciprocal peer partner group as this was pre-specified to compare outcomes between men and women in the reciprocal peer partner group.
Thus, peer coaches are not described in this outcome.
|
12 weeks
|
|
Gender Differences - Mean Contacts Per Buddy Pair
Time Frame: 12 weeks
|
Quantitative and qualitative gender differences in feasibility and acceptance will be evaluated through quantitative differences in enrollment, retention and frequency of peer contacts, and qualitative comparison of participant-reported experiences with intervention content, peer and group interactions by gender.
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Karen Goldstein, MD MSPH, Durham VA Medical Center, Durham, NC
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDX 18-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on reciprocal peer support and non reciprocal coach support
-
US Department of Veterans AffairsCompleted
-
Northwestern UniversityCompletedDepressionUnited States
-
Zhongda HospitalUnknownGlucose Metabolism Disorders | Metabolic Diseases | Endocrine System Diseases | DiabetesChina
-
University of California, San FranciscoAmerican Academy of Family PhysiciansCompleted
-
Nantes University HospitalNot yet recruitingMultiple Sclerosis, Relapsing-remitting
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); Emory University; University of Toronto and other collaboratorsCompletedPerinatal DepressionUnited States
-
Jinan University GuangzhouGuangzhou Sport UniversityCompletedObesity Prevention | Depression - Major Depressive Disorder | Psychological Well BeingChina
-
Universiti Putra MalaysiaNot yet recruitingTreatment Adherence and CompliancePakistan
-
Dartmouth-Hitchcock Medical CenterHarvard University; VinfenCompletedCardiovascular Diseases | Smoking | Obesity | Diabetes | Schizophrenia | Bipolar Disorder | Blood Pressure Disorders | Cholesterol, Elevated | Major Depressive Disorder, RecurrentUnited States
-
University of TennesseeUniversity of Alabama at Birmingham; National Institute on Minority Health...RecruitingCancer | Physical Activity | Cancer Survivor | Cancer SurvivorshipUnited States